Full Name
Dr. Neha Mehta-Shah MD, MSCI
Job Title
Assistant Professor
Company/Affiliation
Washington University School of Medicine
Speaker Bio
Neha Mehta-Shah, MD, MSCI, is Assistant Professor in the Department of Medicine at Washington University School of Medicine in St. Louis. She is a practicing medical oncologist at Siteman Cancer Center.
Dr. Mehta-Shah earned her medical degree from Feinberg School of Medicine, Northwestern University. She completed an internship and residency in internal medicine at New York Presbyterian-Weill Cornell Medical Center and a fellowship in medical hematology/oncology at Memorial Sloan Kettering Cancer Center. She went on to complete a Master’s of Science in Clinical Investigation from Washington University. Dr. Mehta-Shah is board-certified in internal medicine, hematology, and oncology.
Dr. Mehta-Shah’s clinical interests are in Non-Hodgkin lymphoma, Hodgkin lymphoma, and T/NK-cell lymphomas. Her research interests include developing novel therapies and testing those therapies in clinical trials.
Dr. Mehta-Shah is a member of several professional societies and organizations, including the American Society of Hematology (ASH), American Society of Clinical Oncology (ASCO), and American Association for Clinical Research. She also serves on the editorial board of Clinical Lymphomas, Myeloma & Leukemia.
Dr. Mehta-Shah is a member of the NCCN T-Cell/Primary Cutaneous B-Cell Lymphomas Panel.
Dr. Mehta-Shah earned her medical degree from Feinberg School of Medicine, Northwestern University. She completed an internship and residency in internal medicine at New York Presbyterian-Weill Cornell Medical Center and a fellowship in medical hematology/oncology at Memorial Sloan Kettering Cancer Center. She went on to complete a Master’s of Science in Clinical Investigation from Washington University. Dr. Mehta-Shah is board-certified in internal medicine, hematology, and oncology.
Dr. Mehta-Shah’s clinical interests are in Non-Hodgkin lymphoma, Hodgkin lymphoma, and T/NK-cell lymphomas. Her research interests include developing novel therapies and testing those therapies in clinical trials.
Dr. Mehta-Shah is a member of several professional societies and organizations, including the American Society of Hematology (ASH), American Society of Clinical Oncology (ASCO), and American Association for Clinical Research. She also serves on the editorial board of Clinical Lymphomas, Myeloma & Leukemia.
Dr. Mehta-Shah is a member of the NCCN T-Cell/Primary Cutaneous B-Cell Lymphomas Panel.
Speaking At